MK0869

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for MK0869, covering 2017-04-18 to 2017-05-05. Get the full timeline:

Most recent: Clinical Trial Update: Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED) [Phase 3]